SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001732600-18-000001
Filing Date
2018-02-26
Accepted
2018-02-26 15:21:57
Documents
1
Period of Report
2018-02-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2022
  Complete submission text file 0001732600-18-000001.txt   3484
Mailing Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022
Business Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022 212-588-0022
Q BioMed Inc. (Issuer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 MADISON STREET 14TH FLOOR NEW YORK NY 10022
Business Address
Panicucci Rick (Reporting) CIK: 0001732600 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55535 | Film No.: 18640257